2021 State of Clinical Trial Technology Industry Report

How are clinical operations leaders making strategic technology investments in 2021 and beyond?

COVID-19 disrupted clinical trial operations in 2020 and mandated that leaders mitigate physical site access challenges with technology.

Leaders should do three things as they prepare their strategic plans for 2021:

  • Reflect on 2020 and analyze how COVID-19 exposed inefficient clinical operations processes.
  • Understand the clinical operations technology trends that are concrete enough to begin investing in 2021.
  • Recognize the risks to be identified and mitigated in 2021.
  • Prepare yourself for changes coming to the clinical operations landscape over the next three or more years.

This report provides insights from more than 200 respondents to the Florence Industry State of the Industry Survey, from dozens of stakeholders who are members of the Florence Executive Advisory Board, and more than 8,500 study sites and more than 8,000 sponsors using Florence.

Download your free report.

“Florence’s [eISF + Remote Site Access] platform is helping us to respond to the changing environment due to COVID-19 and further progress COVID-19 research with the capability to perform remote monitoring where approved by regulatory authorities and ethics committees.”

Rob Goodwin
Vice President and Head of the Operations Center of Excellence in Global Product Development

2021 State of Industry Clinical Trial Technology Report Cover

You’ll Learn:

  • How COVID-19 impacted site and sponsor technology plans.

  • Why remote site access is now a requirement for clinical operations.

  • Where clinical operations will be investing in 2021.

  • How to avoid failures when selecting technology.

  • What’s on the horizon for clinical trial technology in 2023 and beyond.

  • What steps you need to be taking next year to take part in the new clinical operations model.

Brought to you by the eISF + Remote Site Access Experts

Study Sites
Monthly Monitoring Actions